Neostigmine Methylsulfate Injection
Product Images NDC 14445-413

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 14445-413). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Indoco Remedies Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 03 (Neostig Carton Label 05 mg)

This is a description for a medication called Neostigmine Methylsulfate Injection USP. It comes in a 5mg/10mL (0.5mg/mL) vial for Foririmenous Use and has a 10mL Midspe Dose Vil. The text also mentions NOC 1444541340 Rxonly.*

FDA Label Image

Image 06 (Neostig Carton Label 1mg)

Neostigmine Injection USP for intravenous use is intended for individuals needing a neuromuscular blocking agent. The product is contained within a 10mL vial and each unit contains Neostigmine Methylsulfate. The Intravenous Injection is produced by Indoco Remedies Limited in India and its packaging is labeled with the NDC number and Rxonly. The product should be kept in controlled room temperature and away from light. Instructions for use are included in the package.*

FDA Label Image

Image 04 (Neostig Outer Carton Label 05 mg)

This is a description of Neostigmine Methylsulfate Injection USP, which comes in a 5mg/10mL dosage strength (0.5mg/mL). It is intended for intravenous use and comes in a 10x10mL dose vial. The National Drug Code for this product is 1444541301.*

FDA Label Image

Image 02 (Neostig Vial Label 05mg)

This is a description of a pharmaceutical product with the Pharma Code NDC 14445-413-10 which is a NeOStigmine Methylsulfate injection used for intravenous administration. The injection comes in a 10 mL Multiple Dose Vial and contains 0.2 mg of Trihydrate per mL with the pH adjusted, when necessary, with Sodium Hydroxide / Acetic Acid. The product is manufactured by Indoco Remedies Limited in Verna, Goa, India, and should be stored in the carton to protect from light at 20° to 25°C (68° to 77°F) with permitted excursions to 15° to 30°C (59° to 86°F).*

FDA Label Image

Image 05 (Neostig Vial Label 1mg)

This is a pharmaceutical product with the NDC code 14445-414-10, intended for intravenous use only. It is a solution containing Neostigmine and Methylsulfate with Sodium Acetate and Water for Injection. The drug is manufactured by Indoco Remedies Limited in India and is packaged in a 10 mL multiple-dose vial with a label code of GO/DRUGS/557. It should be protected from light and stored in its original carton at a temperature of 20°C to 25°C (68°F to 77°F), with excursions permitted from 15°C to 30°C (59°F to 86°F). *

FDA Label Image

Image 07 (Nostig Outer Carton 1mg)

This is the label of Neostigmine Methylsulfate Injection USP, a drug that comes in a 10x10 mL Multiple Dose Vial with a concentration of 10 mg/10mL and is intended for intravenous use. The vial must be protected from light, and the manufacturer is Fameges Limited located in Goa, India. There is also a Pharma Code, a National Drug Code (NDC) and an Expiration Date.*

FDA Label Image

Image 01 (Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.